- Home
- SRTS vs DRIO Comparison
SRTS vs DRIO Comparison
Compare SRTS & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRTS | DRIO |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | 60 | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.5M | 61.8M |
| IPO Year | 2016 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SRTS | DRIO |
|---|---|---|
| Price | $4.20 | $8.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $6.67 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 48.8K | 10.0K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 10.12 |
| Revenue | ★ $27,482,000.00 | $7,394,000.00 |
| Revenue This Year | $2.00 | $26.84 |
| Revenue Next Year | $34.23 | $44.98 |
| P/E Ratio | ★ N/A | $0.79 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $3.03 | $0.38 |
| 52 Week High | $5.92 | $17.74 |
Technical Indicators
Market Signals| Indicator | SRTS | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 53.61 | 42.03 |
| Support Level | $4.15 | $7.37 |
| Resistance Level | $4.80 | $9.37 |
| Average True Range (ATR) | 0.24 | 0.81 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 60.76 | 42.66 |
Price Performance
Historical ComparisonAbout SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.